Catalyst Wire Dossier Catalyst Wire Dossier

NT 201 (Botulinum toxin)

Botulinum toxin type A · Merz Pharmaceuticals GmbH
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NT 201 (Botulinum toxin), covering 2026-04-23 to 2026-04-28. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Investigate the Efficacy and Safety of NT 201 (Botulinum Toxin) Compared With Placebo for the Treatment of Adult Participants With Essential Tremor in the Arm [Phase 2]

See pricing